Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2015 Q1 - 2017 Q1
2015^ 2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 268 298 271 267 287 269 268 255 241
20 - 44 3,757 3,625 3,442 3,495 3,727 3,542 3,277 3,431 3,545
45 - 64 12,795 12,093 11,432 11,874 12,734 11,948 11,170 11,598 12,332
65 - 74 8,452 8,129 7,698 8,109 8,972 8,571 7,959 8,217 8,639
75 + 7,586 7,337 6,871 7,105 7,726 7,148 6,658 6,944 7,446
Male 19,207 18,341 17,100 17,969 19,507 18,109 16,901 17,675 18,845
Female 13,651 13,141 12,614 12,881 13,939 13,369 12,431 12,770 13,358
Diabetes 14,998 14,160 13,444 14,531 15,772 14,625 13,568 14,226 14,976
Hypertension 9,536 9,106 8,421 8,344 9,248 8,750 8,287 8,543 8,932
Glomerulonephritis 2,371 2,418 2,241 2,335 2,515 2,284 2,160 2,161 2,313
Cystic kidney 664 693 702 830 919 929 851 820 845
Other urologic 365 344 333 454 449 450 391 420 428
Other cause 2,972 2,912 2,897 3,191 3,304 3,276 2,946 2,955 2,890
Unknown cause 799 739 637 122 142 113 99 97 112
Missing cause 1,153 1,110 1,039 1,043 1,097 1,051 1,030 1,223 1,707
All 32,858 31,482 29,714 30,850 33,446 31,478 29,332 30,445 32,203

^ Data as of June 30, 2017
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2015 Q1 - 2017 Q1
2015^ 2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 7,632 7,647 7,603 7,607 7,648 7,650 7,640 7,574 7,549
20 - 44 105,687 106,105 106,011 105,976 106,136 106,330 106,116 106,099 106,247
45 - 64 304,159 306,731 308,436 310,532 312,892 315,021 316,343 317,456 319,105
65 - 74 160,586 162,895 165,361 167,755 170,271 173,082 175,172 177,241 178,592
75 + 110,419 111,679 113,188 114,482 115,478 116,762 118,106 118,906 119,549
Male 396,813 401,051 404,328 407,984 412,069 415,828 418,579 421,074 423,562
Female 291,596 293,933 296,199 298,297 300,285 302,947 304,728 306,132 307,413
Unknown 74 73 72 71 71 70 70 70 67
Diabetes 262,302 265,090 267,423 270,214 273,171 276,027 277,920 279,412 280,859
Hypertension 175,824 177,857 179,415 180,696 182,323 184,112 185,616 186,859 187,773
Glomerulonephritis 111,441 112,107 112,644 113,146 113,678 114,117 114,433 114,660 114,913
Cystic kidney 32,543 32,789 33,035 33,454 33,888 34,352 34,738 35,109 35,433
Other urologic 11,340 11,386 11,422 11,537 11,592 11,720 11,781 11,877 11,928
Other cause 59,220 59,744 60,227 61,056 61,521 62,210 62,521 62,798 62,926
Unknown cause 25,048 25,051 25,006 24,438 23,931 23,503 23,065 22,601 22,176
Missing cause 10,765 11,033 11,427 11,811 12,321 12,804 13,303 13,960 15,034
All 688,483 695,057 700,599 706,352 712,425 718,845 723,377 727,276 731,042

^ Data as of June 30, 2017
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2015 Q1 - 2017 Q1
2015^ 2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
White 21,143 20,429 19,426 20,106 21,854 20,478 19,163 19,876 20,376
Black/African American 8,590 8,047 7,460 7,880 8,388 7,971 7,288 7,488 8,127
Native American/Alaska Native 304 288 271 263 306 318 282 277 307
Asian 1,296 1,233 1,149 1,210 1,403 1,275 1,195 1,252 1,365
Pacific Islander 356 365 375 364 414 400 389 351 372
Other/Unknown * * . * * * * * *
No ME Form 1,167 1,117 1,033 1,021 1,079 1,034 1,010 1,196 1,650
Hispanic 4,581 4,415 4,038 4,324 4,830 4,317 3,932 4,128 4,288
Non-Hispanic 27,107 25,947 24,643 25,503 27,535 26,126 24,384 25,116 26,259
Unknown * * . * * * * * *
No ME Form 1,167 1,117 1,033 1,021 1,079 1,034 1,010 1,196 1,650
Hemodialysis (%)1 90.75 89.73 89.08 90.12 90.36 89.77 89.2 90.26 90.24
CAPD (%)1 4.67 5.38 5.76 5.24 4.67 4.77 5.01 4.44 4.35
CCPD (%)1 4.55 4.88 5.14 4.63 4.97 5.43 5.76 5.28 5.4
Other (%)1 0.032 0.017 0.021 0.01 0.006 0.023 0.018 0.024 0.01
Unknown (%)1 . . . . . . . . .
Cathether Only (%)2 61.87 61.11 61.37 62.81 62.67 62.27 61.73 63.14 62.68
Catheter w/ maturing AVF (%)2 17.24 16.66 15.71 15.77 16.08 16.65 15.84 15.72 15.62
Catheter w/ maturing AVG (%)2 1.69 1.8 1.82 1.7 1.59 1.65 1.6 1.58 1.58
AVF (%)2 16.17 17.24 17.79 16.53 16.6 16.25 17.25 16.55 16.8
AVG (%)2 2.8 3.01 3.11 3.01 2.86 3.05 3.37 2.82 3.08
Other(%)2 0.2 0.15 0.14 0.14 0.15 0.086 0.17 0.12 0.13
Unknown(%)2 0.035 0.022 0.048 0.046 0.049 0.049 0.04 0.066 0.11
Pre-ESRD EPO(% Yes)3 13.51 13.59 13.67 13.22 13.27 13.1 13.17 13.21 12.77
Pre-ESRD Nephrology(% Yes)3 72.73 73.97 74.53 73.94 74.49 75.47 76.23 75.81 76.4
Mean Serum Albumin(g/dL)4 3.16 3.21 3.23 3.19 3.16 3.2 3.22 3.18 3.17
Mean Serum Creatinine(mg/dL)4 6.57 6.48 6.48 6.47 6.45 6.43 6.45 6.45 6.45
Mean Hemoglobin(g/dL)4 9.4 9.44 9.44 9.35 9.34 9.37 9.4 9.31 9.31
All 32,858 31,482 29,714 30,850 33,446 31,478 29,332 30,445 32,203
All with ME Form 31,691 30,365 28,681 29,829 32,367 30,444 28,322 29,249 30,553
Dialysis Pts with ME Form 31,130 29,736 28,026 29,230 31,830 29,826 27,737 28,708 30,082
Hemodialysis Pts w/ ME Form 28,251 26,681 24,965 26,342 28,762 26,776 24,742 25,911 27,146

^ Data as of June 30, 2017.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.